Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Clinical trial NCT04925284 · COMPLETED

Trial details

NCT number: NCT04925284
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Cervical Cancer SCCHN Pancreatic Cancer Esophageal SCC Metastatic Castration-resistant Prostate Cancer Triple Negative Breast Cancer Hormone Receptor-positive Breast Cancer Epithelial Ovarian Cancer Endometrial Cancer Tissue Factor-Expressing Solid Tumors

Start date: 2021-06-07
Primary completion: 2025-03-10
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.